Related Experiment Video
Updated: Aug 19, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Antifungal drug-resistance mechanisms in Candida biofilms
Jaspreet Kaur1, Clarissa J Nobile2
1Department of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, CA, USA.
Abstract:
Infections caused by the Candida species of human fungal pathogens are a significant medical problem because they can disseminate to nearly every organ of the body. In addition, there are only a few classes of antifungal drugs available to treat patients with invasive fungal infections. Candida infections that are associated with biofilms can withstand much higher concentrations of antifungal drugs compared with infections caused by planktonic cells, thus making biofilm infections particularly challenging to treat. Candida albicans is among the most prevalent fungal species of the human microbiota, asymptomatically colonizing several niches of the body, including the gastrointestinal tract, genitourinary tract, mouth, and skin. Immunocompromised health conditions, dysbiosis of the microbiota, or environmental changes, however, can lead to C. albicans overgrowth, causing infections that range from superficial mucosal infections to severe hematogenously disseminated infections. Here, we review the current knowledge of antifungal drug-resistance mechanisms occurring in Candida biofilms.
Insights
Candida biofilms present a major challenge in treating fungal infections due to their high resistance to antifungal drugs. This review explores the mechanisms behind this drug resistance in Candida biofilms.
Area of Science:
- Mycology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Infections caused by Candida species are a significant global health concern, often leading to disseminated disease.
- Limited classes of antifungal drugs are available for treating invasive fungal infections.
- Candida biofilms exhibit significantly higher antifungal drug resistance than planktonic cells, complicating treatment.
Purpose of the Study:
- To review current knowledge on antifungal drug-resistance mechanisms in Candida biofilms.
- To highlight the challenges posed by biofilm-associated Candida infections.
Main Methods:
- Review of existing literature on Candida biofilms and antifungal drug resistance.
- Analysis of mechanisms contributing to drug tolerance in biofilm structures.
Main Results:
- Candida biofilms possess inherent and adaptive mechanisms conferring resistance to antifungal agents.
- These mechanisms include altered cell wall composition, efflux pump activity, and biofilm matrix production.
Conclusions:
- Understanding these resistance mechanisms is crucial for developing effective therapeutic strategies against Candida biofilm infections.
- Further research is needed to overcome antifungal drug resistance in clinical settings.
Related Concept Videos
Biofilms
Treatment Resistant Cancers
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing

